XGXiang Gao

Xiang Gao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xiang Gao has a total of 49 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Screening and molecular functional analysis of telomere-related genes in abdominal aortic aneurysms based on bioinformatics

    by Tao Yuan, Wei Bi, Yang Liu, Huanhuan Sun, Nanqi Cui, Jian Wang, Jiahao Hou, Runbo Song, Xiang Gao

    Background: Abdominal aortic aneurysm (AAA) is a life-threatening vascular condition characterized by progressive aortic dilation. However, no effective pharmacotherapies exist to halt its progression. This study aimed to investigate telomere-related molecular signatures in AAA to identify potential targets for therapeutic development. Method: We obtained the dataset GSE57691, including the RNA-expression data of AAA and normal control samples, from the GEO database. Weighted Gene Co-expression Network Analysis (WGCNA) was performed using the “WGCNA” package to identify AAA phenotype-related gene modules, and differential expression analysis of differentially expressed genes (DEGs) was conducted using the “limma” package. Biomarker identification was achieved through LASSO and Support Vector Machine (SVM) algorithms using the “glmnet” and “e1071” packages. GSEA_4.2.2 was utilized for gene enrichment analysis, and “CIBERSORT” and “estimate” were employed for immune infiltration. An independent single-cell RNA-seq dataset (GSE237230) was analyzed using the Seurat pipeline to characterize the cellular landscape and validate biomarker expression at single-cell resolution. Finally, the hTFtarget and Encori databases were utilized to construct the transcriptional regulatory network, and the “oncoPredict” package was employed to identify potential drugs. We verified the reliability of the model genes in vitro via the quantification assays (qPCR, western blot and ELISA) and the phenotypic determination assays (flow cytometry and trans-well). Results: Following WGCNA, AAA-related modules (MEmagenta/MEpink) were identified. Intersecting gene modules, DEGs, and telomere genes yielded eight candidates, among which KLF15 and ZBTB16 were prioritized via Lasso and SVM. Low expression of these biomarkers correlated with immune-inflammatory activation, whereas high expression was linked to a suppressive microenvironment that alleviated AAA progression. Furthermore, a transcriptional regulatory network was constructed, identifying key target mRNAs and potential drugs. Single-cell analysis confirmed distinct clusters and specific enrichment of ZBTB16 in B cells. Angiotensin II (Ang II) treatment downregulated KLF15 and ZBTB16 in T/G HA-VSMCs. Overexpression of ZBTB16 attenuated Ang II-induced inflammation, apoptosis, and migration and suppressed MMP-2/9 levels, indicating inhibited migratory activity. Conclusion: We analyzed telomere-related signatures in AAA and identified two crucial biomarkers linked to the immune infiltration of patients. Our findings furthered the understanding of telomere signatures in AAA progression.

  • Open Access

    Bronchial Dieulafoy disease managed with interventional embolization: a case study and literature perspective

    by Tao Yuan, Yang Liu, Jiahao Hou, Kang Shen, Feng Zhang, Xiang Gao

    Bronchial Dieulafoy disease (BDD) is a rare vascular anomaly that can cause severe hemoptysis, often complicating the management of patients with unexplain


  • Open Access

    Cannabidiol protects against acute aortic dissection by inhibiting macrophage infiltration and PMAIP1-induced vascular smooth muscle cell apoptosis

    by Yilong Guo, Yang Che, Xuelin Zhang, Zongna Ren, Yinan Chen, Liliang Guo, Lin Mao, Ren Wei, Xiang Gao, Tao Zhang, et al.


  • Open Access

    H3.3B controls aortic dissection progression by regulating vascular smooth muscle cells phenotypic transition and vascular inflammation

    by Xuelin Zhang, Yang Che, Lin Mao, Dandan Li, Jianqing Deng, Yilong Guo, Quanyi Zhao, Xingzhong Zhang, Li Wang, Xiang Gao, et al.


  • Open Access

    Dl-3-n-Butylphthalide (NBP) Mitigates Muscular Injury Induced by Limb Ischemia/Reperfusion in Mice through the HMGB1/TLR4/NF-κB Pathway

    by Huanhuan Sun, Jueqiong Wang, Wei Bi, Feng Zhang, Kui Chi, Long Shi, Meng Li, Jinwen Zhang, Yanrong Zhang, Xiang Gao

    Objective. Limb ischemia/reperfusion (I/R) injury is a clinical syndrome associated with severe damages to skeletal muscles and other fatal outcomes. Oxidative stress and inflammatory response play vital roles in the development of limb I/R injury. Existing evidence further indicates that Dl-3-n-butylphthalide (NBP) has anti-inflammatory and antioxidative properties. However, whether NBP can protect skeletal muscles from limb I/R injury and the mechanism in mediating the action of NBP treatment still remain to be investigated, which are the focuses of the current study. Methods. The model of limb I/R injury was established and H&E staining was adopted to assess the pathological changes in skeletal muscles following limb I/R injury. Additionally, the W/D ratio of muscle tissue was also measured. ELISA and biochemical tests were carried out to measure the levels of inflammatory cytokines and oxidative stress in mouse models of limb I/R injury. Moreover, the levels of the HMGB1/TLR4/NF-κB pathway-related proteins were also determined using immunohistochemistry and immunoblotting. Results. It was established that NBP treatment alleviated I/R-induced pathological changes in muscular tissue of mice, accompanied by lower W/D ratio of skeletal muscular tissue. Meanwhile, the limb I/R-induced inflammation and oxidative stress in skeletal muscles of mice were also inhibited by NBP. Mechanistic study indicated that the alleviatory effect of NBP was ascribed to inactivation of the HMGB1/TLR4/NF-κB pathway. Conclusions. Our findings highlighted the potential of NBP as a novel strategy for limb I/R-driven muscle tissue damages by suppressing inflammatory response and oxidative stress via the HMGB1/TLR4/NF-κB pathway.


  • Retracted
    Open Access

    Sulforaphane Ameliorates Limb Ischemia/Reperfusion-Induced Muscular Injury in Mice by Inhibiting Pyroptosis and Autophagy via the Nrf2-ARE Pathway

    by Huanhuan Sun, Jueqiong Wang, Wei Bi, Feng Zhang, Kui Chi, Long Shi, Tao Yuan, Kai Ma, Xiang Gao

    Background. Limb ischemia/reperfusion (I/R) injury, as a life-threatening syndrome, is commonly caused by skeletal muscle damage resulting from oxidative stress. Additionally, inflammation-induced pyroptosis and dysregulated autophagy are vital factors contributing to the aggravation of I/R injury. Of note, sulforaphane (SFN) is a natural antioxidant, but whether it worked in limb I/R injury and the possible mechanism behind its protection for skeletal muscle has not been clearly established. Methods. Effects of SFN on limb I/R-injured skeletal muscle were assessed by HE staining, followed by assessment of wet weight/dry weight (W/D) ratio of muscle tissues. Next, ELISA and biochemical tests were used to measure the inflammatory cytokine production and oxidative stress. Immunofluorescent analysis and Western blot were adopted to examine the level of pyroptosis- and autophagy-related proteins in vivo. Moreover, protein levels of Nrf2-ARE pathway-related factors were also examined using Western blot. Results. SFN treatment could protect skeletal muscle against limb I/R injury, as evidenced by diminished inflammation, pyroptosis, autophagy, and oxidative stress in skeletal muscles of mice. Further mechanistic exploration confirmed that antioxidative protection of SFN was associated with the Nrf2-ARE pathway activation. Conclusions. SFN activates the Nrf2-ARE pathway, and thereby inhibits pyroptosis and autophagy and provides a novel therapeutic strategy for the limb I/R-induced muscle tissue damage.


  • Open Access

    The Application of Single-Cell Technologies in Cardiovascular Research

    by Yinan Chen, Yang Liu, Xiang Gao

    Cardiovascular diseases (CVDs) are the leading cause of deaths in the world. The intricacies of the cellular composition and tissue microenvironment in heart and vasculature complicate the dissection of molecular mechanisms of CVDs. Over the past decade, the rapid development of single-cell omics technologies generated vast quantities of information at various biological levels, which have shed light on the cellular and molecular dynamics in cardiovascular development, homeostasis and diseases. Here, we summarize the latest single-cell omics techniques, and show how they have facilitated our understanding of cardiovascular biology. We also briefly discuss the clinical value and future outlook of single-cell applications in the field.


  • Open Access

    ceRNAs in Cancer: Mechanism and Functions in a Comprehensive Regulatory Network

    by Ni Yang, Kuo Liu, Mengxuan Yang, Xiang Gao

    Noncoding RNAs have been shown with powerful ability in post-transcriptional regulation, enabling intertwined RNA crosstalk and global molecular interaction in a large amount of dysfunctional conditions including cancer. Competing endogenous RNAs (ceRNAs) are those competitively binding with shared microRNAs (miRNAs), freeing their counterparts from miRNA-induced degradation, thus actively influencing and connecting with each other. Constantly updated analytical approaches boost outstanding advancement achieved in this burgeoning hotspot in multilayered intracellular communication, providing new insights into pathogenesis and clinical treatment. Here, we summarize the mechanisms and correlated factors under this RNA interplay and deregulated transcription profile in neoplasm and tumor progression, underscoring the great significance of ceRNAs for diagnostic values, monitoring biomarkers, and prognosis evaluation in cancer.


  • Open Access

    MiR-203 Targets to the 3′-UTR of SLUG to Suppress Cerebral Infarction-Induced Endothelial Cell Growth and Motility

    by Yunsong Li, Wei Bi, Bing Han, Tao Yuan, Long Shi, Yang Liu, Huanhuan Sun, Xueyan Li, Xiang Gao

    Cerebral infarction is one of the leading causes of death worldwide, in which angiogenesis plays a critical role. On the other hand, accumulating evidence has demonstrated that microRNAs (miRNAs) function as key modulators in the formation and progression of cerebral infarction. However, the molecular mechanisms of miRNAs underlying cerebral infarction-associated angiogenesis remain unclear. In the present study, we indicated that the expression of miR-203 was significantly downregulated in serum samples derived from patients with cerebral infarction and in mice brain samples following middle cerebral artery occlusion (MCAO) compared with healthy controls. In vitro, the expression of miR-203 was obviously downregulated in hypoxia-induced human umbilical vein vascular endothelial cells (HUVECs). Functionally, ectopic expression of miR-203 drastically suppressed HUVEC proliferation, invasion, and migration. In addition, SLUG, a zinc finger transcriptional repressor, was identified as a direct target of miR-203 and was negatively correlated with miR-203 expression in MCAO mice and in hypoxia-induced HUVECs. Furthermore, overexpression of SLUG reversed the inhibitory effect of miR-203 on proliferation, invasion, and migration abilities of HUVECs. Taken together, our research provides a novel insight of the miR-203-SLUG axis into cerebral infarction-associated endothelial behaviors and may offer a powerful therapeutic target of cerebral ischemia.


  • Open Access

    Protective Role of Sulodexide on Renal Injury Induced by Limb Ischemia-Reperfusion

    by Tao Yuan, Ni Yang, Wei Bi, Jinwen Zhang, Xueyan Li, Long Shi, Yang Liu, Xiang Gao

    Background. Though widely known as a potent antithrombin agent with protective effects on the kidney and other remote organs, it is currently ambiguous when it comes to sulodexides function on ischemia-reperfusion (I/R) injury. With this research, we pursued to further explore how sulodexide exerts its influence on limb I/R injury, in which deleterious effects on the kidney were what we primarily focused on. Methods. We randomized twenty-four C57BL/6 male rats into three groups, namely, sham operation group (control group), I/R group, and sulodexide pretreatment group. Hematoxylin and eosin staining was applied for discovery of renal histological changes. Serum creatinine (Cr) and serum urea nitrogen (BUN) were measured. Apoptotic parameters were detected by the TdT-mediated dUTP Nick-End Labeling method. To what extent and levels that antiapoptotic and proapoptotic proteins were expressed could be sensitively revealed by immunohistochemistry assay. Lipid peroxidation product propylene glycol and inflammatory factors were examined by enzyme-linked immunosorbent assay. Additionally, an extracorporeal hypoxia-reoxygenation (H/R) model of human renal proximal tubule epithelial HK2 cells was established. Our targets lay in cell proliferation and apoptosis, and we used western blotting to reflect apoptosis-related gene expression. Results. The levels of serum BUN, Cr, and inflammatory factors in sulodexide-intervened rats manifested significant reduction when compared with the I/R group. Also, sulodexide could protect the kidney from histological changes and could effectively inhibit intraparenchymal apoptosis. Furthermore, adding 2μl/mL or 5μl/mL of sulodexide to H/R model cells in vitro gave rise to significant restoration of the degenerative proliferation capacity of the HK2 cells following H/R injury and late cellular apoptosis experienced dramatic reduction versus the H/R group. When treated with 5μl/mL of sulodexide at a dose of 10mg/kg, the levels of the antiapoptotic proteins were increased, while the proapoptotic proteins showed opposite trends. Notable escalation on antiapoptotic protein expression level, in contrast with the opposite trends exhibited in proapoptotic proteins, was observed with 5μl/mL sulodexide pretreatment with the dosage being 10mg/kg. Conclusion. Sulodexide can protect against kidney damage caused by I/R injury of the lower limbs by enhancing cell proliferation, inhibiting apoptosis, reducing inflammatory reactions, and scavenging oxygen free radicals.